A flight carrying the primary lot of Sputnik V vaccines from Russia, landed in Hyderabad, Telangana on Saturday.
Last month, the Drug Controller General had issued permission for Dr Reddy’s Laboratories to import the Russian vaccine to India for emergency use.
The rollout of the Russian vaccine is anticipated to reinforce India’s third section of the vaccination drive which commenced on Saturday amid a file rise in COVID-19 circumstances.
India for the primary time has reported greater than 4 lakh new COVID-19 circumstances in the final 24 hours. A complete of 4,01,993 contemporary COVID-19 circumstances have been recorded in the final 24 hours taking the cumulative depend of the circumstances to 1,91,64,969.
Sputnik V is the third vaccine India has given the go-ahead to after ‘Covishield’, developed by Oxford University and AstraZeneca and ‘Covaxin’, the indigenous vaccine manufactured by Bharat Biotech.
Covishield is manufactured by the Serum Institute of India.
Earlier, the Indian envoy to Russia Bala Venkatesh Varma had mentioned that India expects between 150,000 to 200,000 ready-made vaccines to be obtainable in a short time in the early half of May.
Diplomatic sources had mentioned that India will get a substantive quantity of vaccines in the primary tranche and the availability will proceed in installments. India is anticipating 5 million vials of Sputnik vaccines by the subsequent month.